Who Makes Up the Modern Dementia Care Team?
It takes even more than a village to provide the comprehensive care needed for aging, neurocognitive patients, says Rajesh R. Tampi, MD, MS.
The Developing Dementia Definition, Treatment Field
Rajesh R. Tampi, MD, MS, discusses the evolved definition of dementia as a cognitive disorder, and how its spectrum of symptoms impact clinical development.
Organizations Call on FDA To Help Address Recurrent C Difficile Burdens
Christian Lillis of the Peggy Lillis Foundation for C. Diff Education & Advocacy discusses the need for greater industry-organization support and drug development.
Kenneth Chapman, MD: Interpreting Global Perspectives on GINA Asthma Recommendations
Results from the 2 APPaRENT trials suggest regular inhaled corticosteroids/LABA alone or with short-acting beta agonists were the preferred treatment approach with physicians.
Bradley Richmond, MD, PhD: How Smoke Might Influence Ciliated Cell Function in COPD
Dr. Richmond speaks to the newest pulmonology data from Vanderbilt University that was presented at ATS 2022.
Al Rizzo, MD: Detailing the Latest Data on Pulmonary Health from ATS 2022
Dr. Rizzo sits down with HCPLive to discuss the impact of air pollution and allergies on pulmonary health, as well as new research on pulmonary arterial hypertension.
Tara Vijayan, MD: Doctors Fighting Misinformation
Dr. Tara Vijayan talks about how primary care physicians can be best combat misinformation.
Sanjiv Chopra, MD: Liver Disease During the COVID-19 Pandemic
Alcohol use increased during the COVID-19 pandemic, leading to an increase in alcoholic hepatitis.
Tara Vijayan, MD: Combating Drug Scarcity
High-risk individuals should be targeted when drug scarcity comes into play.
Tara Vijayan, MD: Targeting the Right Population for COVID-19 Treatments
There remains a need to develop more antivirals that can be easily scaled up for COVID-19.
How Viloxazine Extended-Release Capsules Alter Adult ADHD Care
Theresa R. Cerulli, MD, discusses the known clinical profile and evidential potential of the newest non-stimulant ADHD drug for adults.
Ty Gluckman, MD: Cardiovascular Concerns in 2022
There is concern for cardiovascular patients over missed screenings during the pandemic.
The Unique Signs and Struggles of Adult ADHD
On the heels of the FDA approval of viloxazine extended-release capsules for adult ADHD, a neuropsychiatrist discusses the state of care and diagnosis among older patients.
Pass The Study: An Injected Stem Cell for Patients with Geographic Atrophy
In the first episode of this new game show, a team of ARVO 2022 investigators work to invent an innovative clinical trial.
Anticipating the Ophthalmology Gene Therapy Pipeline
From curative stem cell approaches to in-clinic subretinal injections, Arshad Khanani, MD, MA, navigates what the future drug class may entail.
Preparing for the First Geographic Atrophy Therapies
An FDA decision could come as soon as this year. One expert stresses the need for improved screening, biomarker research, and patient communication beforehand.
Gene Therapy RGX-314 Benefits nAMD Treatment Burden in Phase 2 AAVIATE
Study author Arshad Khanani, MD, MA, discusses how the novel-targeting gene therapy candidate may uniquely benefit patients with treated retina disease.
How Geographic Atrophy Impacts Functional Outcomes
Theodore Leng, MD, MS, discusses his team's IRIS registry findings suggesting a need for quantifying how vision-loss patients are impacted by functional or quality-of-life measures.
Rethinking Psychiatry With Dr. Steve Levine: Episode 3
Dr. Levine is joined by Dr. Sanjay Mathew to talk about some exciting treatments in the pipeline for psychiatric disorders.
Advances in Anti-VEGF Administration: From Port Delivery to Subcutaneous
Veeral S. Sheth, MD, MBA, gives an update on his practice's adoption of the novel PDS in patients with AMD—and discusses other potential methods of anti-VEGF delivery.
Progression in Complement Inhibitors, Retina Gene Therapies
Veeral S. Sheth, MD, MBA, discusses promising agents in development for geographic atrophy and other under-addressed ophthalmic diseases.
What Fish Oil Supplements May Provide to Retina Disease Management
An ARVO 2022 study author discusses her team's research into omega-3 fatty acids for diseases including dry AMD.
Phase 4 Elevatum Trial Will Observe Faricimab In Underrepresented DME Populations
Matthew Cunningham, MD, explains the need for greater inclusion of impacted races and ethnicities in ophthalmic clinical trials.
Sarcoidosis Screening, Clinical Research Improving with Awareness Efforts
How To Better Track, Interpret Air Quality Data
Stephanie Lovinsky-Desir, MD, MS, discusses key findings from the 2022 ALA State of the Air Report.
The Uterine Fibroid Treatment and Telemedicine Landscape
Erica Marsh, MD, MSCI, discusses the role of new drug classes like GnRH antagonists, as well as the adoption of remote screening options following COVID-19 response.
How Racial Disparities, Personal Stigma Persist in Uterine Fibroid Care
Erica Marsh, MD, MSCI, discusses the need for improved patient involvement and open discussion in the highly prevalent, potentially psychologically impactful condition.
State of the Science: Managing C Difficile Infections
There are several emerging treatments for C difficile infections.
What's Driving Turnover in Health Care During COVID-19?
Bianca K. Frogner, PhD, discusses the prevalence of burnout and job dissatisfaction observed across various health care worker roles and settings.
Miriam Vos, MD: Future Research For Pediatric NAFLD
ALT can be used a marker for NAFLD severity in pediatric patients.
